Orbactiv Launch Strategy Will Focus On Savings From Avoiding Hospitalization
This article was originally published in The Pink Sheet Daily
Executive Summary
The novel antibiotic will fit well into a treatment paradigm moving more toward outpatient care, The Medicines Co. execs explained to investors. The firm will stress cost savings, reduced need for hospitalization and a virtual guarantee of patient compliance.